PLANTARC BIO LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 272 ILa | -3.00% |
|
-1.09% | -19.26% |
Valuation
| Fiscal Period: December | 2021 | 2022 |
|---|---|---|
| Capitalization 1 | 24.89 | 26.2 |
| Enterprise Value (EV) 1 | 7.24 | 11.96 |
| P/E ratio | -3.85 x | -5.24 x |
| Yield | - | - |
| Capitalization / Revenue | - | 26,19,94,030 x |
| EV / Revenue | - | 26,19,93,888 x |
| EV / EBITDA | -4.21 x | -5.36 x |
| EV / FCF | -1,25,97,917 x | -1,67,79,690 x |
| FCF Yield | -0% | -0% |
| Price to Book | 1.4 x | 1.93 x |
| Nbr of stocks (in thousands) | 3,309 | 3,309 |
| Reference price 2 | 7.520 | 7.917 |
| Announcement Date | 24/03/22 | 23/03/23 |
1ILS in Million2ILS
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales | - | - | - | - | - | 0.1 |
| EBITDA 1 | -1.228 | -2.499 | -2.058 | -2.024 | -5.913 | -4.884 |
| EBIT 1 | -1.477 | -2.737 | -2.224 | -2.109 | -5.998 | -4.952 |
| Operating Margin | - | - | - | - | - | -4,952% |
| Earnings before Tax (EBT) 1 | -1.469 | -2.728 | -2.15 | -2.299 | -6.456 | -4.982 |
| Net income 1 | -1.469 | -2.728 | -2.15 | -2.299 | -6.456 | -4.982 |
| Net margin | - | - | - | - | - | -4,982% |
| EPS 2 | -4.897 | -9.093 | -7.170 | -7.663 | -1.951 | -1.510 |
| Free Cash Flow | - | - | -1.237 | -0.9885 | -1.975 | -1.561 |
| FCF margin | - | - | - | - | - | -1,561.38% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 05/11/20 | 05/11/20 | 05/11/20 | 27/03/21 | 24/03/22 | 23/03/23 |
1ILS in Million2ILS
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - |
| Net Cash position | - | 1.51 | 2.73 | 0.94 | 17.6 | 14.2 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow | - | - | -1.24 | -0.99 | -1.98 | -1.56 |
| ROE (net income / shareholders' equity) | - | - | -86.1% | -103% | -68.3% | -31.8% |
| ROA (Net income/ Total Assets) | - | - | -45.8% | -43.3% | -35.9% | -18.2% |
| Assets 1 | - | - | 4.694 | 5.308 | 17.97 | 27.32 |
| Book Value Per Share | - | 5.640 | 10.90 | 3.910 | 5.350 | 4.110 |
| Cash Flow per Share | - | 5.020 | 9.480 | 3.560 | 5.380 | 1.900 |
| Capex 1 | 0.03 | 0.01 | 0.01 | 0.04 | 0.17 | 0.09 |
| Capex / Sales | - | - | - | - | - | 92% |
| Announcement Date | 05/11/20 | 05/11/20 | 05/11/20 | 27/03/21 | 24/03/22 | 23/03/23 |
1ILS in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- PLNT Stock
- Financials PlantArc Bio Ltd.